AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (July 31, 2007). doi:10.1152/ajpendo.00271.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/4/E1036    most recent
00271.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xin, X.
Right arrow Articles by Chakrabarti, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xin, X.
Right arrow Articles by Chakrabarti, S.
Submitted on May 1, 2007
Accepted on July 24, 2007

Akt Activation and Augmented Fibronectin Production in Hyperhexosemia

Xiping Xin1, Shali Chen1, Zia Ali Khan2, and Subrata Chakrabarti1*

1 Pathology, The University of Western Ontario, London, Canada
2 Surgery, Harvard Medical School, Boston, Massachusetts, United States

* To whom correspondence should be addressed. E-mail: schakrab{at}uwo.ca.

Dysmetabolic state in diabetes leads to augmented synthesis of extracellular matrix(ECM) proteins. In the endothelial cells, we have previously demonstrated that glucose-induced fibronectin(FN) and its splice variant EDB+FN production are regulated by protein kinase B(PKB, a.k.a Akt). Here we investigated role of Akt1 in ECM protein production in the organs affected by chronic diabetic complications. We studied Akt1/PKB{alpha} knockout mice and wild-type controls. To avoid confounding effects of systemic insulin, we used 30% galactose feeding to induce hyperhexosemia for 8 weeks starting at 6 weeks of age. We investigated FN mRNA, EDB+FN mRNA, and transforming growth factor(TGF{beta}) mRNA expression, Akt phosphorylation, Akt kinase activity, and NF{kappa}B and AP-1 activation in the retina, heart and kidney. Renal and cardiac tissues were histologically examined. Galactose feeding caused significant upregulation of FN, EDB+FN and TGF-{beta} in all tissues. FN protein levels paralleled mRNA. Such upregulation were prevented in Akt1-deficient galactose-fed mice. Galactose feeding caused ECM protein deposition in the glomeruli and in the myocardium, which were prevented in the Akt-knockout mice. NF{kappa}B and and AP-1 activation was pronounced in galactose-fed wild-type mice and were prevented in galactose-fed Akt1/PKB{alpha} deficient group. In the retina and kidney, serine 473 was predominant site for Akt phosphorylation whereas in the heart it was threonine 308. Parallel experiment in streptozotocin-induced diabetic animals showed similar results. The data from this study indicate that hyperhexosemia-induced Akt/PKB activation is an important mechanism leading to NF-{kappa}B and AP-1 activation and increased ECM protein synthesis in the organs affected by chronic diabetic complications.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. Feng, S. Chen, J. Chiu, B. George, and S. Chakrabarti
Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level
Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E1119 - E1126.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.